Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 27, 2017		Jan. 29, 2016
OPERATING ACTIVITIES:
Net income	$ 40,747		$ 52,431
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	21,057		20,228
Amortization	2,906		2,793
Stock-based compensation	10,574		4,435
Changes in certain assets and liabilities:
(Increase)/decrease in accounts and notes receivable	97,224		176,042
(Increase)/decrease in inventories and other assets	(65,296)		(89,991)
Increase/(decrease) in trade accounts payable and other accrued liabilities	(106,170)		(131,574)
Increase/(decrease) in income taxes, net	(20,848)		(23,865)
Increase/(decrease) in other non-current liabilities	2,518		12,638
Other	139		(2,648)
Net cash provided by (used in) operating activities	(17,149)		20,489
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(28,697)		(24,117)
Acquisition of businesses, net of cash acquired	0		(5,698)
Purchase of noncontrolling interest	(5,820)		0
Cash proceeds on disposal of assets	980		6,753
Decrease in restricted cash	(25)		(76)
Net cash used in investing activities	(33,562)		(23,138)
FINANCING ACTIVITIES:
Payments of debt	(45)		(45)
Net change in other borrowings	3		5,850
Net proceeds (repayments) of commercial paper	65,702		(450)
Proceeds from stock options exercised	892		6,454
Treasury stock purchases	0		(18,134)
Excess tax benefit from stock-based compensation	1,043		4,429
Dividends paid	(30,151)		(26,063)
Net cash provided by (used in) financing activities	37,444		(27,959)
Decrease in cash and cash equivalents	(13,267)		(30,608)
Effect of exchange rate changes on cash and cash equivalents	(7,773)		(3,677)
Cash and cash equivalents at beginning of period	174,720	[1]	185,961
Cash and cash equivalents at end of period	$ 153,680		$ 151,676

[1] The Balance Sheet at October 28, 2016 has been derived from the audited consolidated financial statements at that date.